Structure and cytotoxicity of biodegradable poly(D,l-lactide-co-glycolide) nanoparticles loaded with oxaliplatin

被引:15
作者
Razuvaeva, Ekaterina, V [1 ]
Kalinin, Kirill T. [1 ]
Sedush, Nikita G. [1 ]
Nazarov, Alexey A. [2 ]
Volkov, Dmitry S. [2 ]
Chvalun, Sergei N. [1 ,3 ]
机构
[1] Natl Res Ctr Kurchatov Inst, Moscow 123182, Russia
[2] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119991, Russia
[3] Russian Acad Sci, NS Enikolopov Inst Synthet Polymer Mat, Moscow 117393, Russia
基金
俄罗斯科学基金会;
关键词
lactide; glycolide; poly(lactide-co-glycolide); nanoparticles; oxaliplatin; drug delivery system; PLGA NANOPARTICLES; PARTICLE-SIZE; DELIVERY; DEGRADATION; DRUGS;
D O I
10.1016/j.mencom.2021.07.025
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Spherical nanoparticles based on the biocompatible and biodegradable poly(D,l-lactide-co-glycolide) copolymer (90 : 10) loaded with oxaliplatin were produced by nanoprecipitation. Effect of the oxaliplatin loading on structure, size and morphology of the copolymer particles is considered. The nanoformulation of oxaliplatin demonstrates enhanced cytotoxicity and selectivity in vitro against several cancer cells compared with the free drug.
引用
收藏
页码:512 / 514
页数:3
相关论文
共 24 条
[1]   Platinum-Based Antitumor Drugs and Their Liposomal Formulations in Clinical Trials [J].
Arantseva, D. A. ;
Vodovozova, E. L. .
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2018, 44 (06) :619-630
[2]  
Balaban'yan V.Yu., 2013, BIOFARM ZH, V5, P28
[3]   Effect of Oxaliplatin-Loaded Poly (d,l-Lactide-co-Glycolic Acid) (PLGA) Nanoparticles Combined with Retinoic Acid and Cholesterol on Apoptosis, Drug Resistance, and Metastasis Factors of Colorectal Cancer [J].
C. de S. L. Oliveira, Ana Luiza ;
Araujo Junior, Raimundo Fernandes de ;
Gomes de Carvalho, Thais ;
B. Chan, Alan ;
Schomann, Timo ;
Tamburini, Filippo ;
de Geus-Oei, Lioe-Fee ;
J. Cruz, Luis .
PHARMACEUTICS, 2020, 12 (02)
[4]   Block Copolymer Micelles in Nanomedicine Applications [J].
Cabral, Horacio ;
Miyata, Kanjiro ;
Osada, Kensuke ;
Kataoka, Kazunori .
CHEMICAL REVIEWS, 2018, 118 (14) :6844-6892
[5]  
Darr A J, 2013, J BIOMED SCI ENG, V6, P586, DOI [10.4236/jbise.2013.65074, DOI 10.4236/JBISE.2013.65074]
[6]   Platinum-based drugs: past, present and future [J].
Dilruba, Shahana ;
Kalayda, Ganna V. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) :1103-1124
[7]   Role of hydrolytic degradation of polylactide drug carriers in developing micro- and nanoscale polylactide-based drug dosage forms [J].
Ermolenko, Yu. V. ;
Semyonkin, A. S. ;
Ulianova, Yu. V. ;
Kovshova, T. S. ;
Maksimenko, O. O. ;
Gelperina, S. E. .
RUSSIAN CHEMICAL BULLETIN, 2020, 69 (08) :1416-1427
[8]   NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT [J].
FESSI, H ;
PUISIEUX, F ;
DEVISSAGUET, JP ;
AMMOURY, N ;
BENITA, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) :R1-R4
[9]   Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells [J].
Gryparis, Evangelos C. ;
Hatziapostolou, Maria ;
Papadimitriou, Evangelia ;
Avgoustakis, Konstantinos .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 67 (01) :1-8
[10]  
Kadina Y. A., MOLECULES, V2021, P602